Literature DB >> 23692609

Cross-linked gelatin microspheres with continuously tunable degradation profiles for renal tissue regeneration.

Monica A Serban1, Toyin Knight, Richard G Payne, Joydeep Basu, Elias A Rivera, Neil Robbins, Darell McCoy, Craig Halberstadt, Deepak Jain, Timothy A Bertram.   

Abstract

Collagen and gelatin-based biomaterials are widely used in tissue engineering applications. Various methods have been reported for the cross-linking of these macromolecules for the purpose of delaying their biodegradation to prolong their in vivo residence (in tissue engineering applications) or tailoring their drug releasing capacity (when used as drug carriers). In this study, a carbodiimide-based cross-linking method, also used in the production of United States Food and Drug Administration-approved products, was employed to obtain differentially cross-linked gelatin beads. The colorimetric determination of the in vitro enzymatic susceptibility of the beads indicated that the resistance to degradation linearly correlated with the concentration of carbodiimide used for the cross-linking reaction. This result was also confirmed in vivo by the histological evaluation of the residence time of orthotopically injected cell-seeded beads. These data would indicate that the production of gelatin-based microbeads with tunable degradation profiles might be applicable toward the development of products that catalyze regeneration of kidney and other solid organs.
© 2013 International Union of Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  beads; biodegradation; cross-linked; gelatin; kidney; tissue engineering

Mesh:

Substances:

Year:  2013        PMID: 23692609     DOI: 10.1002/bab.1125

Source DB:  PubMed          Journal:  Biotechnol Appl Biochem        ISSN: 0885-4513            Impact factor:   2.431


  1 in total

1.  Gelatin-methacrylamide gel loaded with microspheres to deliver GDNF in bilayer collagen conduit promoting sciatic nerve growth.

Authors:  Hai Zhuang; Shoushan Bu; Lei Hua; Mohammad A Darabi; Xiaojian Cao; Malcolm Xing
Journal:  Int J Nanomedicine       Date:  2016-04-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.